Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar 11;291(11):5473-5483.
doi: 10.1074/jbc.M115.695379. Epub 2016 Jan 14.

Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43

Affiliations

Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43

Takashi Nonaka et al. J Biol Chem. .

Abstract

Intracellular aggregates of phosphorylated TDP-43 are a major component of ubiquitin-positive inclusions in the brains of patients with frontotemporal lobar degeneration and ALS and are considered a pathological hallmark. Here, to gain insight into the mechanism of intracellular TDP-43 accumulation, we examined the relationship between phosphorylation and aggregation of TDP-43. We found that expression of a hyperactive form of casein kinase 1 δ (CK1δ1-317, a C-terminally truncated form) promotes mislocalization and cytoplasmic accumulation of phosphorylated TDP-43 (ubiquitin- and p62-positive) in cultured neuroblastoma SH-SY5Y cells. Insoluble phosphorylated TDP-43 prepared from cells co-expressing TDP-43 and CK1δ1-317 functioned as seeds for TDP-43 aggregation in cultured cells, indicating that CK1δ1-317-induced aggregated TDP-43 has prion-like properties. A striking toxicity and alterations of TDP-43 were also observed in yeast expressing TDP-43 and CK1δ1-317. Therefore, abnormal activation of CK1δ causes phosphorylation of TDP-43, leading to the formation of cytoplasmic TDP-43 aggregates, which, in turn, may trigger neurodegeneration.

Keywords: ALS (Lou Gehrig disease); TAR DNA-binding protein of 43 kDa (TDP-43); casein kinase 1δ; frontotemporal lobar degeneration (FTLD); phosphorylation; protein aggregation; protein kinase.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Biochemical evidence of phosphorylated TDP-43 aggregation by CK1δ1-317. Shown are immunoblot analyses of proteins extracted from SH-SY5Y cells co-expressing both TDP-43 and either empty vector, Myc-tagged CK1α1, Myc-tagged CK1α2, Myc-tagged CK1δ, Myc-tagged CK1ϵ, FLAG-tagged CK1δ1-317, HA-tagged CK2, HA-tagged Cdc-7, or FLAG-tagged ASK. Proteins were extracted from cells with 1% Sarkosyl, and the Sar-sup and Sar-ppt were subjected to immunoblot analyses. The blots were probed using anti-phosphorylated TDP-43 (anti-pS409/410) polyclonal and anti-TDP-43 monoclonal (anti-TDP mono) antibodies, a mixture of anti-Myc monoclonal and anti-FLAG monoclonal antibodies, a mixture of anti-HA monoclonal and anti-FLAG monoclonal antibodies, and anti-tubulin α antibody. Because FLAG-CK1δ1-317 is predicted to be ∼35 kDa, the band of ∼43 kDa may correspond to its ubiquitinated form. Note that the band of phosphorylated TDP-43 is observed in the Sar-sup and Sar-ppt of cells expressing CK1δ1-317 (arrowheads).
FIGURE 2.
FIGURE 2.
Microscopic analyses of phosphorylated TDP-43 inclusions by CK1δ1-317. Shown are confocal microscopic analyses of cells expressing TDP-43 alone, FLAG-CK1δ1-317 alone, or both. These cells were immunostained with anti-phosphorylated TDP-43 (pS409/410) polyclonal, anti-FLAG monoclonal, anti-ubiquitin (Ub) monoclonal, and anti-p62 monoclonal antibodies and counterstained with Hoechst 33342. Scale bars = 20 nm.
FIGURE 3.
FIGURE 3.
Time course characterization of cells expressing TDP-43 and CK1δ1-317. Shown are immunoblot analyses of cells expressing TDP-43 alone, FLAG-CK1δ1-317 alone, or both. Sar-sup and Sar-ppt fractions were prepared from cells and subjected to immunoblot analyses. The blots were probed using anti-phosphorylated TDP-43 (anti-pS409/410) monoclonal, anti-TDP-43 monoclonal (anti-TDP mono), anti-FLAG monoclonal, and anti-tubulin α antibodies. Note that endogenous TDP-43 is phosphorylated and aggregated in cells expressing FLAG-CK1δ1-317 alone. The arrowheads show phosphorylated TDP-43.
FIGURE 4.
FIGURE 4.
The physiological properties of TDP-43 are altered in cells co-expressing TDP-43 and CK1δ1-317. A, CFTR exon 9 skipping assay of transfected cells. Gel electrophoresis of the RT-PCR products of RNA from transfected cells was performed. The RNAs from SH-SY5Y cells transfected with the reporter plasmid pSPL3-CFTR exon 9 plus pcDNA3.1 expression vectors were used as templates for RT-PCR analysis. The products were analyzed by electrophoresis in 1.5% agarose gel. The band intensities (−exon 9) were quantified and the results are expressed as mean + S.E. (n = 3). ****, p < 0.0001 by Student's t test. a.u., arbitrary unit. B, quantification of endogenous HDAC6 mRNA levels in several transfected cells by real-time PCR. The mRNA ratio of HDAC6/hypoxanthine-guanine phosphoribosyltransferase (HPRT) is expressed as mean ± S.E. (n = 3). *, p < 0.05 by Student's t test.
FIGURE 5.
FIGURE 5.
Kinase activity of CK1δ1-317 is required for the accumulation of phosphorylated TDP-43. Shown are immunoblot analyses of cells expressing FLAG-CK1δ1-317 WT, K38R (KR), or K38A (KA) with or without TDP-43. Sar-sup and Sar-ppt were prepared from cells and subjected to immunoblot analyses. The blots were probed using anti-phosphorylated TDP-43 (anti-pS409/410) monoclonal, anti-FLAG monoclonal, and anti-tubulin α antibodies. Note that endogenous TDP-43 is phosphorylated and aggregated in cells expressing the WT alone. The arrowhead shows phosphorylated TDP-43.
FIGURE 6.
FIGURE 6.
Phosphorylation at Ser-393/395 of TDP-43 is important for its aggregation induced by CK1δ1-317. A, mass spectrometric identification of phosphorylation sites of aggregated TDP-43 induced by CK1δ1-317. Red Ser residues are phosphorylation sites of intracellular accumulated TDP-43 by CK1δ1-317. B, immunoblot analyses of non-transfected cells (lane 1), cells expressing FLAG-CK1δ1-317 alone (lane 2), and cells co-expressing FLAG-CK1δ1-317 and either TDP-43 wild-type (lane 3), S393A/S395A (lane 4), S403A/S404A (lane 5), or S393A/S395A/S403A/S404A (lane 6) mutant. Sar-sup and Sar-ppt were prepared from cells and subjected to immunoblot analyses. The blots were probed using anti-phosphorylated TDP-43 (anti-pS409/410) monoclonal, anti-TDP monoclonal (anti-TDP mono), and anti-tubulin α antibodies. The arrowheads shows phosphorylated TDP-43. C, the immunoreactivity of phosphorylated TDP-43 (arrowheads in B) of Sar-ppt positive for anti-pS409/410 (top panel) and anti-TDP monoclonal antibody (bottom panel) was quantified, and the results are expressed as mean ± S.E. (n = 3). **, p < 0.01 by Student's t test; n.s., not significant. a.u., arbitrary unit.
FIGURE 7.
FIGURE 7.
Insoluble phosphorylated TDP-43 functions as seeds for intracellular TDP-43 aggregation. Confocal microscopic analyses of cells expressing TDP-43 ΔNLS alone, cells treated with the Sar-ppt prepared from cells expressing TDP-43 and FLAG-CK1δ1-317 (Sar-ppt seeds), and cells expressing TDP-43 ΔNLS and treated with Sar-ppt seeds. These cells were immunostained with anti-phosphorylated TDP-43 (pS409/410) polyclonal antibody and counterstained with Hoechst 33342. Scale bars = 20 nm.
FIGURE 8.
FIGURE 8.
Cytotoxic effects of phosphorylated TDP-43 aggregates induced by CK1δ1-317 in yeast. A, spotting assay to compare cytotoxicity in yeast cells expressing TDP-43 alone, cells expressing CK1δ1-317 alone, and cells expressing both TDP-43 and CK1δ1-317. We used serial dilutions of yeast cells transformed with galactose-inducible constructs. Transformants were spotted on agar plates with (inducing) or without (non-inducing) galactose, and growth was assessed after 48 h. B, immunoblot analyses of yeast cells expressing TDP-43 alone, cells expressing CK1δ1-317 alone, and cells expressing both TDP-43 and CK1δ1-317. Sar-sup and Sar-ppt were prepared from these cells and subjected to immunoblot analyses. The blots were probed using anti-TDP-43 monoclonal (anti-TDP mono) and anti-phosphorylated TDP-43 (anti-pS409/410) monoclonal antibodies. C, immunofluorescence analyses of yeast cells expressing GFP-tagged TDP-43 (TDP-43-GFP) alone and cells expressing both TDP-43-GFP and CK1δ1-317. Cells were counterstained with Hoechst 33342. Note that GFP-positive aggregates (arrowheads) can be observed in cells expressing TDP-43-GFP and CK1δ1-317.

Similar articles

Cited by

References

    1. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602–611 - PubMed
    1. Neumann M., Sampathu D. M., Kwong L. K., Truax A. C., Micsenyi M. C., Chou T. T., Bruce J., Schuck T., Grossman M., Clark C. M., McCluskey L. F., Miller B. L., Masliah E., Mackenzie I. R., Feldman H., Feiden W., Kretzschmar H. A., Trojanowski J. Q., and Lee V. M. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 - PubMed
    1. Ayala Y. M., De Conti L., Avendaño-Vázquez S. E., Dhir A., Romano M., D'Ambrogio A., Tollervey J., Ule J., Baralle M., Buratti E., and Baralle F. E. (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277–288 - PMC - PubMed
    1. Ayala Y. M., Zago P., D'Ambrogio A., Xu Y. F., Petrucelli L., Buratti E., and Baralle F. E. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778–3785 - PubMed
    1. Buratti E., and Baralle F. E. (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front. Biosci. 13, 867–878 - PubMed

Publication types